Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Five Major Univ. & Hospital Trauma Centers to Use QuikClot(R) Combat Gauze(TM) in Clinical Trials

Abstract:
Z-Medica Corporation (Z-Medica), a medical products company focused on innovative hemostatic nano-technologies, today announced that it has been awarded a $2.9 million contract from the United States Navy and Marine Corps to fund large-scale human studies on stopping bleeding in penetrating wounds, using the company's new QuikClot(R) Combat Gauze(TM). The U.S. Department of Defense Committee on Tactical Combat Casualty Care recently selected QuikClot(R) Combat Gauze(TM) as the firstline hemorrhage treatment for tourniquet-resistant wounds for all branches of the U.S. military.

Five Major Univ. & Hospital Trauma Centers to Use QuikClot(R) Combat Gauze(TM) in Clinical Trials

WALLINGFORD, CT | Posted on September 24th, 2008

The clinical studies will take place at five major university and hospital trauma centers: Johns Hopkins University in Baltimore; the University of Miami; the University of Massachusetts Medical School in Worcester, Mass.; Vanderbilt University in Nashville; and Hartford Hospital in Hartford, Conn. Specifically, the study will address small entry/large exit wounds from high velocity bullets, traumatic injuries frequently encountered on the battlefield.

'We are proud to support the U.S. Navy and Marine Corps in their medical mission and are gratified that they selected the best available hemostatic agent for these important studies that will result in new knowledge and medical techniques for saving both military and civilian lives,' said Z-Medica CEO Raymond J. Huey.

QuikClot(R) Combat Gauze(TM) combines surgical gauze with a proprietary inorganic material that stops arterial and venous bleeding in seconds. The material, pliable and familiar to medical personnel, can be fitted to any size or shape wound -- including penetrating wounds. It is easily removed once the bleeding stops. The product comes in rolls four yards long by three inches wide.

Prior to its deployment earlier this year, QuikClot(R) Combat Gauze(TM) was tested in pre-clinical trials at the Naval Medical Research Center, the University of California, Santa Barbara, the University of Massachusetts Medical School and at various field facilities. It has 510(k) clearance from the U.S. Food & Drug Administration.

In addition to QuikClot(R) Combat Gauze(TM), Z-Medica manufacturers and markets QuikClot(R) brand hemostatic agent and QuikClot(R) ACS+(TM) for military use, QuikClot(R) 1st Response(TM) for first responders and a suite of consumer first aid products including QuikClot(R) NoseBleed(TM), the first to be based on the new hemostatic gauze technology. More than one million units of QuikClot(R) are deployed in the U.S. and 36 countries worldwide.

####

About Z-Medica Corporation (Z-Medica)
Z-Medica Corporation headquarters is located at 4 Fairfield Blvd., Wallingford, Connecticut 06492. For more information, please call (203) 294-0000.

For more information, please click here

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Thanks for the memory: NIST takes a deep look at memristors January 20th, 2018

New Method Uses DNA, Nanoparticles and Top-Down Lithography to Make Optically Active Structures: Technique could lead to new classes of materials that can bend light, such as for those used in cloaking devices January 18th, 2018

Arrowhead Pharmaceuticals Announces Pricing of Underwritten Public Offering of Common Stock January 18th, 2018

Leti to Demo New Curving Technology at Photonics West that Improves Performance of Optical Components January 18th, 2018

Nanomedicine

Arrowhead Pharmaceuticals Announces Pricing of Underwritten Public Offering of Common Stock January 18th, 2018

Leti to Demo New Curving Technology at Photonics West that Improves Performance of Optical Components January 18th, 2018

Ultra-thin optical fibers offer new way to 3-D print microstructures: Novel approach lays groundwork for using 3-D printing to repair tissue in the body January 17th, 2018

Arrowhead Pharmaceuticals Announces Proposed Underwritten Offering of Common Stock January 17th, 2018

Announcements

Thanks for the memory: NIST takes a deep look at memristors January 20th, 2018

New Method Uses DNA, Nanoparticles and Top-Down Lithography to Make Optically Active Structures: Technique could lead to new classes of materials that can bend light, such as for those used in cloaking devices January 18th, 2018

Arrowhead Pharmaceuticals Announces Pricing of Underwritten Public Offering of Common Stock January 18th, 2018

Leti to Demo New Curving Technology at Photonics West that Improves Performance of Optical Components January 18th, 2018

Military

New Method Uses DNA, Nanoparticles and Top-Down Lithography to Make Optically Active Structures: Technique could lead to new classes of materials that can bend light, such as for those used in cloaking devices January 18th, 2018

New exotic phenomena seen in photonic crystals: Researchers observe, for the first time, topological effects unique to an “open” system January 12th, 2018

Nanotube fibers in a jiffy: Rice University lab makes short nanotube samples by hand to dramatically cut production time January 11th, 2018

Ultrafine fibers have exceptional strength: New technique developed at MIT could produce strong, resilient nanofibers for many applications January 5th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project